1. David J. Miller, R.Ph., M.S., Ph.D., FIACP, FACA
Curriculum Vitae
Contact
7945 Morse Lake Ave SE
Alto, MI 49302
(616) 308-7774 (mobile)
(616) 974-9792 (work)
E-mail: drdave@keystonepharm.com
Education
1996 Ph.D. Pharmaceutics. The University of Michigan, College of
Pharmacy, Ann Arbor, M1 48109-1065.
Major Professor: Gordon L. Flynn, Ph.D.
Graduation Date: October 1996
Grade point average: 8.000 on an 8.000 scale
1994 M.S., Ph.D. Pharmaceutics. The University of Michigan, College of
Pharmacy, Ann Arbor, M1 48109-1065.
Major Professor: Gordon L. Flynn, Ph.D.
Graduation Date: October 1994
Grade point average: 8.000 on an 8.000 scale
1990 B.S. Pharmacy, Ferris State University, College of Pharmacy, Big Rapids,
MI 49327.
Graduation Date: November 1990
Grade point average: 3.80 on a 4.00 scale
Professional Experience
1) 2003-Present Keystone Pharmacy, Inc., 4021 Cascade Rd. SE., Grand Rapids, MI 49546
Owner, Manager, and Chief Formulation Scientist. Keystone Pharmacy has been PCAB
accredited since 2009.
2) 2000-2003 Aciont Inc., 350 West 800 North Suite 250, Salt Lake City, UT 84103. Director of
Research and Development.
3) 1992-2006 Staff Pharmacist, Rite Aid, Inc., Harrisburg PA.
4) 1998-2000 lomed Inc., 1290 West 2320 South Suite D, Salt Lake City, UT 841l9. Project
Team Leader, Ophthalmic Drug Delivery.
5) 1996-1998 Dermion, Inc., 1290 West 2320 South Suite D, Salt Lake City,
UT 84119 (Former division of lomed). Iontophoretic scientist.
6) 1991-1996 The University of Michigan, College of Pharmacy, Ann Arbor MI 48109-1065.
Graduate researcher in pursuit of a M.S. and Ph.D. in pharmaceutics.
7) 1993 Iomed, Inc., Salt Lake City, UT 84119. Iontophoretic Scientist Internship.
8) 1992 Abbott Laboratories, North Chicago, IL 60064. Internship.
9) 1991 The University of Michigan. Teaching Assistant in pharmacy practice.

2. Professional Courses Attended
1) PCCA Aseptic Compounding Course (2011) Presented by the Professional Compounding
Centers of America, Houston, TX.
2) Internationa1 Academy of Compounding Pharmacists (2006-2013). International Symposium
and Compounders on Capitol Hill. Washington DC
3) PCCA International Seminar (2009-2013) Presented by the Professional Compounding
Centers of America, Houston, TX.
4) PCCA Pain Conference (2006). Presented by the Professional Compounding Centers of
America. Lansing, MI
5) PCCA Compounding Essentials Course (2003). Presented by the Professional Compounding
Centers of America, Houston, TX.
6) Patents and Patent Law (2001). Presented by the Center for Professional
Advancement in Baca Raton, FL.
7) FDA Approval Processes (2000). Presented by the Center for Professional
Advancement in Boca Raton, Fl.
8) Basic Project Management (1999). Presented by the Center for Professional
Advancement in Salt Lake City, UT.
9) Biostatistics for the Non-Statistician (1997). Presented by the Center for
Professional Advancement in San Francisco, CA.
Patents, Publications and Presentations
1) Miller DJ, Li SKL and Higuchi WI. US Patent 7,785,578 issued 8/2010. Non-invasive Ocular
Drug Delivery.
2) Miller DJ, Higuchi WI, Li SKL, and Flynn GL. US Patent 7,137,975 issued 11/2006. Method
for Increasing the Battery life of an alternating current Iontophoresis using a barrier-modifying
agent.
3) Miller DJ, Higuchi WI, Li SKL and Hastings MS. US patent 6,801,804 issued 10/2004.
Device and method for monitoring and controlling electrical resistance at a tissue site
undergoing Iontophoresis.
4) Hastings MS, Li SKL, Miller DJ, Bernstein PS, Mufson D (2004). Visulex™: Advancing
Iontophoresis for Effective Noninvasive Back-of-the-eye Therapeutics. Drug Del Tech, 4(3):2-
6.
5) Miller DJ, Li SKL and Higuchi WI. US patent 6,553,255 issued 4/2003. Use of background
electrolytes to minimize flux variability during Iontophoresis.
6) Miller DJ, Higuchi WI, Li SK, and Flynn GL. U.S. patent applications in decreasing the
Sensation and Potential Irritation Associated with lontophoretic Treatments (CIPs to Patents
091783,696 and 091783,138)
7) Miller DJ, Li SKL, and Higuchi WI. U.S. patent application #09/698,697: Use of Background
Electrolytes to Minimize Flux variability During Iontophoresis Zhu H, Miller DJ, Liddell MR.
Higuchi WI, Li SK (2001).
8) Zhu H, Miller DJ, Lidell MR, Higuchi W, Li SKL. Systematic Study of the Transport Properties of
Human Skin During Constant Conductance AC Iontophoresis. AAPS PharmSci, 3(3). Presented
at the 2001 AAPS Annual Meeting
9) Liddell MR, Zhu J, Miller DJ, Higuchi WI, Li SKL (2001). Selection of Background
Electrolytes to Minimize Flux Variability During Constant Current DC Transdermal

3. Iontophoresis (2001) AAPS PharmSci, 3(3). Presented at the 2001 AAPS Annual Meeting
10)Yang G, Li SK, Zhu H, Liddell MR, Miller DJ, Higuchi WI (2001). Evaluation of Flux
Enhancement During AC Iontophoresis with Different Size Permeants AAPS PharmSci, 3(3).
Presented at the 2001 AAPS Annual Meeting
11)Lloyd LB, Vollmer DL, Berardi T, Szlek M, Kolb K, Miller D. Parkinson T, and Hamilton S
(2001). Transscleral Iontophoresis of Amikacin: Quantitative Determination of Delivery and
Distribution in Rabbit Eyes. Invest Ophthalmol Vis Sci, 42(4), 5172.
12)Miller DJ, Desjardins J, Abbot E, Chlipala E, Bendele A (2000), Distribution of Amikacin in
the Rabbit Eye Following Transscleral Iontophoresis. Invest Ophthalmol Vis Sci, 42(4), 8767
13)Miller DJ, Desjardin J, Abbott E, Chipala E, Bendele A (2000). Transscleral Iontophoresis of
Amikacin in the Rabbit Eye Following Transscleral Iontophoresis. Presented at the 3rd
International Symposium on Ocular Pharmacology and Pharmaceutics in Lisbon Portugal on
February 12, 2000.
14)Parkinson TM, Miller DJ, Lloyd LB, Hamilton S, Kolb K, Brown S, Koss A, Beck J and
Blouin P (2000). The Effects of an in vivo Iontophoresis on Rabbit Eye Structure and Retinal
Function. Invest Ophthalmol Vis Sci, 41(4); S772
15)Miller DJ, Kolb KK. Lloyd LB (J 998). The Effect of Ion-exchange Membranes on the
Iontophoretic Flux of Three Model Permeants Through Hairless Mouse Skin In-vitro. Pharm
Res. lS(l):S-527.
16)Miller DJ and Flynn GL (1996). The Effects of Direct Current Iontophoretic Parameters on
Irritation and Drug Flux of a Model Permeant; Dexamethasone Sodium Phosphate. Pharm
Res. 13(9): S-254. September 1996.
17)Miller DJ and Flynn GL (1995). The Effects of In Vivo Direct Current Iontophoretic
Parameters on Epidermal Barrier Function and Turnover Kinetics. Pharm Res. 12(9):S-246,
September 1995.
18)Miller DJ and Flynn GL (l995). The Effects of In Vivo Direct Current Iontophoretic
Parameters on Epidermal Barrier Function and Turnover Kinetics. Presented as a poster at the
27th annual Pharmaceutics Graduate Student Meeting at The University of Michigan
19)Miller DJ (1995). The Effects of In-vivo Direct Current Iontophoresis on TransEpidermal Water
Loss (TEWL) and Epidermal Cell Turnover Kinetics. Presented as a seminar to the faculty,
staff, students and friends of the University of Michigan College of Pharmacy February 1,
1995.
20)Miller DJ and Flynn GL (1994). Trans-epidermal Water Loss (TEWL) Changes Following In-
Vivo Iontophoresis. Pharm Res. 11(10);S-t86, October, 1994.
21)Miller DJ and Flynn GL (1994). The Immediate Effects of an Acute In-vitro Iontophoretic
Treatment on Skin Microstructure. Presented as a poster to the 14th annual graduate student
symposium in the pharmacological sciences and biorelated chemistry. The University of
Michigan, March 5, 1994.
22)Miller DJ (1993), Novel Drug Delivery Systems and Oral Peptide Delivery. Presented as a
seminar to the faculty, staff, students and friends of the University of Michigan College of
Pharmacy November 6, 1993.
Awards and Recognitions
2015-Present Awarded fellowship in the American College of Apothecaires
2012-Present Awarded fellowship in the International Academy of Compounding Pharmacists
2011 Professional Compounding Centers of America Pharmacist of the Month (July)
1996 Recipient of the Upjohn Enz award (The University of Michigan)
I am also honored to have received the American Association of Governing

4. Boards Award, the Perry Drug Store Scholarship Award, the Upjohn
Community Service Award, the Michigan Pharmacists Association
Professionalism Award, the Burroughs Wellcome Scholarship Award, and
the Drug Education Award as well as numerous others. I am a member of
the Rho Chi pharmacy honor society.
Additional Professional Activities and Board Memberships
• 2012-Present Member, Board of Directors: International Academy of Compounding
Pharmacists
• 2012-Present Founding Member of the Compounding Council of the Michigan
Pharmacists Association
• 2010-2013, Member, Board of Director: Partners in Pharmacy Cooperative
• 2007-2011, Member, Board of Directors: Kent County Pharmacists Association
• 2009-2010, President, Board of Directors: Kent County Pharmacists Association
• 2005-2009, Member, Board of Directors: Partners in Pharmacy Cooperative
• 2008-2009, President, Board of Directors: Partners in Pharmacy Cooperative
• 2006-2008, Member, Board of Directors: East Paris Business Association
• 2004-2005, Member, Board of Directors: Michigan Pharmacists Association Political
Action Committee
Professional Memberships
• International Academy of Compounding Pharmacists since 2005
• Michigan Pharmacist's Association since 2003.
• American Association of Pharmaceutical Scientists (both PDD and PPDM sections 1994-
2003).
• Controlled Release Society 1998-2003
• American Diabetes Association 200 l-2003
• American Association of Research in Vision and Ophthalmology (ARVO), 1999-2002
Military Enlistment
I am proud to be a veteran of the United States Army. I served in the ll3th United States Army
Band from 1983 through 1986. I was honorably discharged in August 1986 having achieved the
rank of Sergeant (E5). I was the recipient of numerous military awards and letters of
recommendation from superior officers. Most notable of these awards was being named Soldier
of the Year; Fort Knox, KY (1985).
Licensure
I am currently licensed to practice pharmacy in the state of Michigan.
Available upon request.
References